Fundraising Fox
/People
Sign in

Thomas Clozel

InvestorUnicorn founder

Co-Founder and Chief Executive Officer at AI biotech · Founder, Chief Executive Officer at Owkin

New York, New York, United States

FoundedAI biotech$1B

Find your path to Thomas

509 people in our graph share verified history with Thomas — schools, employers, funds. One of them is your warm intro.

Jonathan UseroviciunlockedThomas: together at Bioptimus (2024–2026)
×3Thomas: together at Bioptimus
×3Thomas: together at 8400 The Health Network
Thomas: together at Hôpital Necker-Enfants Malades

About

Thomas Clozel is a medical doctor and the CEO and co-founder of Owkin, a company focused on applying artificial intelligence to drug development and patient care.

Co-Founder and Chief Executive Officer at AI biotech

Intro paths

→

In turn, Thomas can intro founders to AI biotech's investors below.

AI biotech's investors · 9

Alpha Intelligence CapitalSan FranciscoBridford Investments (Bridford Group)LondonCathay InnovationParis · $5M – $40M checksF-Prime CapitalCambridge · $3M – $10M checksFrstParis · $2M checksGV (Google Ventures)Mountain View · $250K – $50M checksOTB VenturesAmsterdam · $1.1M – $7.7M checksPlug and Play VenturesSunnyvale · $50K – $12M checksSanofi VenturesCambridge · $5M checks · since 2021

Co-founders at AI biotech

GW
Gilles WainribCo-Founder and Former Chief Scientific Officer

Experience

  1. OWKINCEO and Co-foundercurrent2016 — presentNew York City Metropolitan Area
  2. BioptimusNon operational cofounder and Board Dlrectorcurrent2024 — present
  3. XPRIZEBrain trustcurrent2024 — presentRégion de la baie de San Francisco
  4. Université Paris-SaclayMember Board of Directorscurrent2024 — presentVille de Paris, Île-de-France, France
  5. Cure51Non operational cofoundercurrent2024 — present
  6. EQT GroupAdvisorcurrent2025 — present
  7. Sofinnova PartnersVenture advisorcurrent2022 — presentVille de Paris, Île-de-France, France
  8. GRACEAdvisorcurrent2023 — present
  9. Fragment (YC S23)Seed Investor2023
  10. Osium AI (YC S23)Seed Investor2023
  11. 8400 The Health NetworkGlobal expert2023District de Tel Aviv, Israël
  12. DioxycleInvestor2022
  13. KanjiSeed Investor2022
  14. Spot - justspot.ioSeed Investor2021
  15. Resilience careSeed Investor2021
  16. Patch BiosciencesSeed Investor2020
  17. CHU Henri Mondor de CréteilClinical Assistant Professor2012 — 2014Paris Area, France
  18. Weill Cornell Medical CollegeResearch Fellow2009 — 2012
  19. Hôpital Necker-Enfants MaladesInternat2006 — 2012
  20. Biochimie, Cellules, Cibles Thérapeutiques (BC2T)Master 2 parcours recherche2009 — 2010

Skills & more

Clinical Research74Public Health48Hematology37Cancer18Research8Oncology4Cell4Laboratory3Clinical Trials5Molecular Biology8Cell Biology2Lifesciences2
+8 moreCell CultureLife SciencesArtificial IntelligenceEntrepreneuriatHealthClinicalRecherche cliniqueSanté publique

Languages English · French · German

From Thomas's professional profile.

Deals · 1

BioptimusSolo GP

via Owkin · filed Feb 2024

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Frequently asked questions

Who is Thomas Clozel?
Thomas Clozel is a medical doctor and the CEO and co-founder of Owkin, a company focused on applying artificial intelligence to drug development and patient care.
Where does Thomas Clozel work?
Thomas Clozel is Co-Founder and Chief Executive Officer of AI biotech and Founder, Chief Executive Officer at Owkin.
What companies did Thomas Clozel found?
Thomas Clozel founded AI biotech.
Where did Thomas Clozel go to school?
Thomas Clozel studied at Joan & Sanford I. Weill Medical College of Cornell University (research fellowship, Hematology-oncology); Icahn School of Medicine at Mount Sinai (Clinical rotation, Neurology Department).

Same school

Shared employers